Literature DB >> 10217912

Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.

M J Olek1, B Bordeaux, R T Leshner.   

Abstract

Charcot-Marie-Tooth disease type 1, also known as hereditary motor sensory neuropathy type 1, is an uncommon autosomal dominant disease that causes destruction of peripheral nerves with a varied clinical course, but often leads to muscle weakness. If the peroneal muscle is involved, the patient may develop a characteristic slapping gait. The dose-limiting side effect of the chemotherapeutic agent vincristine is usually its neurotoxicity. We report the case of a 5-year-old patient with leukemia who developed an acute polyneuropathy after treatment with vincristine. Charcot-Marie-Tooth disease type 1 was diagnosed in the patient and, subsequently, in his mother only after vincristine toxicity was observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217912     DOI: 10.7556/jaoa.1999.99.3.165

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  6 in total

1.  A novel system to accelerate the progression of nerve degeneration in transgenic mouse models of neuropathies.

Authors:  Osefame Ewaleifoh; Minh Trinh; John W Griffin; Thien Nguyen
Journal:  Exp Neurol       Date:  2012-06-09       Impact factor: 5.330

Review 2.  Vincristine-induced peripheral neuropathy in pediatric cancer patients.

Authors:  Erika Mora; Ellen M Lavoie Smith; Clare Donohoe; Daniel L Hertz
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

3.  Successful treatment of nasopharyngeal cancer using radiotherapy with concurrent cetuximab in a patient with Charcot-Marie-Tooth disease.

Authors:  Alexandra Nicoleta Budure; Eric Winquist; David Palma; Rohann Jonathan Mark Correa
Journal:  BMJ Case Rep       Date:  2019-07-15

4.  Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1).

Authors:  Patrick P Hess; Monica S Ventura Ferreira; Benjamin Rolles; Martin Kirschner; Florian Holtbernd; Mareike Tometten; Tim H Brümmendorf; Fabian Beier
Journal:  Clin Case Rep       Date:  2022-05-05

5.  Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.

Authors:  Andreas S Beutler; Amit A Kulkarni; Rahul Kanwar; Christopher J Klein; Terry M Therneau; Rui Qin; Michaela S Banck; Ganesh K Boora; Kathryn J Ruddy; Yanhong Wu; Regenia L Smalley; Julie M Cunningham; Nguyet Anh Le-Lindqwister; Peter Beyerlein; Gary P Schroth; Anthony J Windebank; Stephan Züchner; Charles L Loprinzi
Journal:  Ann Neurol       Date:  2014-09-17       Impact factor: 10.422

6.  Acute neurotoxicity following vincristine due to Charcot-Marie-Tooth disease in a young child with medulloblastoma.

Authors:  Trisha Kissoon; Sridharan Gururangan; John Sladky
Journal:  Neurooncol Pract       Date:  2019-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.